6533b835fe1ef96bd129ec20
RESEARCH PRODUCT
Synthesis, physicochemical characterization, cytotoxicity, antimicrobial, anti-inflammatory and psychotropic activity of new N-[1,3-(benzo)thiazol-2-yl]-ω-[3,4-dihydroisoquinolin-2(1H)-yl]alkanamides.
Tatiana EremkinaAlla ZablotskayaAthina GeronikakiVizma NikolajevaIrina ShestakovaMarina PetrovaIzolda SegalLiga ZvejnieceSergey Belyakovsubject
Models MolecularAntifungal AgentsStereochemistrymedicine.drug_classInfrared spectroscopyAntineoplastic AgentsMicrobial Sensitivity TestsCarrageenanCrystallography X-RayAnti-inflammatorychemistry.chemical_compoundMiceStructure-Activity RelationshipSeizuresCell Line TumorDrug DiscoverymedicineAnimalsEdemaHumansBenzothiazolesThiazoleCytotoxicityHypoxiaPsychomotor AgitationCell ProliferationPharmacologyPsychotropic DrugsBacteriaDose-Response Relationship DrugMolecular StructureTetrahydroisoquinolineChemistry PhysicalOrganic ChemistryAnti-Inflammatory Agents Non-SteroidalFungiGeneral MedicineCarbon-13 NMRAntimicrobialIsoquinolinesPropanamideAnti-Bacterial AgentschemistryNIH 3T3 CellsDrug Screening Assays AntitumorAnesthesia Inhalationdescription
Abstract A series of new N-[(benzo)thiazol-2-yl]-2/3-[3,4-dihydroisoquinolin-2(1H)-yl]ethan/propanamide derivatives was synthesized and characterized by 1H, 13C NMR and IR spectroscopy and mass-spectrometry. A single crystal X-ray study of N-(1,3-benzothiazol-2-yl)-2-[3,4-dihydroisoquinolin-2(1H)-yl]ethanamide is reported to determine its conformational feature. The investigated compounds were found to be active in psychotropic in vivo, anti-inflammatory in vivo and cytotoxicity in vitro screening. They possess marked sedative action, reveal high anti-inflammatory activity, have selective cytotoxic effects and NO-induction ability concerning tumour cell lines. Some of the compounds synthesized demonstrate antimicrobial action. An attempt was made to correlate the biological results with their structural characteristics and physicochemical parameters. Some specific combinations of types of activities for the synthesized compounds have been revealed.
year | journal | country | edition | language |
---|---|---|---|---|
2012-12-28 | European journal of medicinal chemistry |